Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA 20 275

Opportunity Information: Apply for PA 20 275

The NIH Successor-in-Interest (Type 6 Parent Clinical Trial Optional) opportunity (PA 20-275) is designed for organizations that already hold certain active NIH awards and need to request a change in the official recipient organization for that award. In practical terms, it is a formal pathway to ask NIH to transfer an existing grant from the current grantee institution to a new legal entity that is assuming the original organization s responsibilities, such as after a merger, acquisition, reorganization, or other institutional change. This is not a typical competition for new research or program funding; it is an administrative mechanism to keep an existing NIH-supported project in place when the institution behind it is changing.

These requests are treated as prior approval actions under the NIH Grants Policy Statement (specifically the section covering change of recipient organization), meaning the request is reviewed as an administrative decision rather than scored like a traditional grant application. Submissions made under this FOA are routed directly to the Grants Management Specialist associated with the current award, rather than going through a standard peer review process. NIH emphasizes that even if an organization submits a successor-in-interest request through this opportunity, approval is not automatic and there is no guarantee the award will be transferred. Applicants are strongly encouraged to talk with the awarding NIH Institute or Center before submitting, because the awarding component will ultimately determine whether the proposed new recipient can assume the award and whether the transfer is appropriate.

The opportunity is listed as a discretionary grant mechanism with activity areas spanning education, environment, food and nutrition, health, income security, and social services, and it is associated with CFDA 93.113. The FOA includes a broad range of eligible applicant types across government, education, nonprofit, and private sectors. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); small businesses; and other entities. NIH also explicitly calls out additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. (foreign) organizations, reflecting that successor situations can occur across many institutional settings.

Key administrative details in the listing include an original closing date of 2023-07-23 and a creation date of 2020-10-01. The notice does not specify an award ceiling or expected number of awards because the action is not meant to fund brand-new projects; instead, it addresses whether an already-funded project can continue under a different recipient organization. Overall, the main purpose of PA 20-275 is to provide a standardized NIH route for institutions to request a transfer of an existing NIH grant when organizational control changes, while making clear that NIH approval is required, review is handled through grants management, and early coordination with the awarding Institute or Center is an important step before submission.

• The National Institutes of Health in the education, environment, food and nutrition, health, income security and social services sector is offering a public funding opportunity titled "Successor-in-Interest (Type 6 Parent Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113.
• This funding opportunity was created on 2020-10-01.
• Applicants must submit their applications by 2023-07-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 20 275

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: